Related Experiment Videos
Gentamicin and albumin-bilirubin binding. An in vivo study
Insights
Gentamicin does not affect bilirubin levels or binding in newborns. This study confirms that gentamicin is safe for neonatal use, showing no impact on bilirubin-albumin binding capacity.
Area of Science:
- Neonatal pharmacology
- Clinical toxicology
- Pediatric drug safety
Background:
- Jaundice is common in newborns, often treated with phototherapy or medication.
- Gentamicin is an antibiotic frequently used in neonatal intensive care units.
- Concerns exist regarding potential drug interactions affecting bilirubin metabolism in infants.
Purpose of the Study:
- To investigate the in vivo effect of gentamicin on bilirubin-albumin binding in newborn infants.
- To determine if serum gentamicin concentrations correlate with changes in bilirubin levels or binding capacity.
- To provide clinical data supporting the safety of gentamicin in neonates regarding bilirubin metabolism.
Main Methods:
- Ten newborn infants received intramuscular gentamicin.
- Serum samples were collected over a 12-hour postinjection period.
- Measurements included total binding capacity of serum albumin for bilirubin and serum bilirubin concentrations.
Main Results:
- No significant changes in total binding capacity of serum albumin for bilirubin were observed.
- Serum bilirubin levels remained stable throughout the 12-hour observation period.
- No correlation was found between serum gentamicin concentrations and bilirubin-albumin binding or bilirubin levels.
Conclusions:
- Gentamicin administration does not alter bilirubin-albumin binding in newborn infants.
- The findings support in vitro data suggesting gentamicin's safety concerning bilirubin metabolism.
- Gentamicin can be safely used in neonates without compromising bilirubin clearance mechanisms.
Abstract:
Ten newborn infants were given gentamicin intramuscularly. Over a postinjection interval of 12 hours, no significant change occurred in the total binding capacity of serum albumin for bilirubin or in concentrations of serum bilirubin levels. There was no correlation between concentrations of serum gentamicin and the total binding capacity or serum bilirubin. This study provides in vivo data that supports recent in vitro experiments showing that gentamicin does not alter bilirubin-albumin binding.